Dong-A Socio Holdings Co., Ltd. logo

Dong-A Socio Holdings Co., Ltd. (000640)

Market Closed
9 Jun, 06:30
KRX SM KRX SM
118,700. 00
+4,800
+4.21%
739.11B Market Cap
- P/E Ratio
2,800% Div Yield
42,796 Volume
- Eps
113,900
Previous Close
Day Range
115,000 120,500
Year Range
90,582.52 124,757.28
Earnings results expected in 43 days

Summary

000640 closed today higher at ₩118,700, an increase of 4.21% from yesterday's close, completing a monthly increase of 5.6% or ₩6,300. Over the past 12 months, 000640 stock gained 11.15%.
000640 is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
Dong-A Socio Holdings Co., Ltd. has completed 1 stock splits, with the recent split occurring on Apr 08, 2013.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Want to track 000640 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000640 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Dong-A Socio Holdings Co., Ltd. Dividends

Dong-A Socio Holdings Co., Ltd. logo
000640 2 months ago
Other
₩1,000 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 11 months ago
Other
₩679.61 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 27 Dec 2023
Other
₩1,165.05 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 29 Jun 2023
Other
₩970.87 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 28 Dec 2022
Other
₩970.87 Per Share

Dong-A Socio Holdings Co., Ltd. Earnings

23 Jul 2025 (43 Days) Date
-
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
-
Cons. EPS
-
EPS
29 Oct 2024 Date
-
Cons. EPS
-
EPS
14 Aug 2024 Date
2.38K
Cons. EPS
2.76K
EPS
Dong-A Socio Holdings Co., Ltd. logo
000640 2 months ago
Other
₩1,000 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 11 months ago
Other
₩679.61 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 27 Dec 2023
Other
₩1,165.05 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 29 Jun 2023
Other
₩970.87 Per Share
Dong-A Socio Holdings Co., Ltd. logo
000640 28 Dec 2022
Other
₩970.87 Per Share
23 Jul 2025 (43 Days) Date
-
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
-
Cons. EPS
-
EPS
29 Oct 2024 Date
-
Cons. EPS
-
EPS
14 Aug 2024 Date
2.38K
Cons. EPS
2.76K
EPS

Dong-A Socio Holdings Co., Ltd. (000640) FAQ

What is the stock price today?

The current price is ₩118,700.00.

On which exchange is it traded?

Dong-A Socio Holdings Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 000640.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 739.11B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has Dong-A Socio Holdings Co., Ltd. ever had a stock split?

Dong-A Socio Holdings Co., Ltd. had 1 splits and the recent split was on Apr 08, 2013.

Dong-A Socio Holdings Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Min-Young Kim CEO
KRX SM Exchange
KR7000640003 ISIN
KR Country
- Employees
- Last Dividend
13 Mar 2025 Last Split
- IPO Date

Overview

Dong-A Socio Holdings Co., Ltd. is a prominent entity in the pharmaceutical domain, both within South Korea and on a global scale. Founded in 1932, the company has its headquarters in Seoul, South Korea. It is reputed for its significant contributions to pharmaceutical research and development, particularly focusing on various therapeutic areas including type 2 diabetes, obesity, overactive bladder, anemia, HIV-1, and cancer, among others. Besides its core pharmaceutical business, Dong-A Socio Holdings extends its expertise into healthcare solutions, CDMO services, production of imaging equipment, mineral water, and also ventures into IT and construction services.

Products and Services

  • DA-1241 - A groundbreaking development aimed at treating type 2 diabetes and non-alcoholic steatohepatitis.
  • DA-1726 - An oxyntomodulin analogue for obesity treatment, showcasing the company's dedication to addressing metabolic disorders.
  • DA-1229 - A dipeptidyl peptidase-4 inhibitor, reflecting the company's innovation in diabetes management.
  • DA-8010 - A muscarinic M3 receptor antagonist developed for the treatment of overactive bladder, highlighting the company's focus on improving quality of life.
  • DMB-3115 - A biosimilar of Stelara, targeted at inflammatory disease treatment, demonstrating the company's competence in biosimilars.
  • DA-3880 - An innovative solution for anemia treatment, underpinning the firm's dedication to comprehensive healthcare.
  • STP0404 - An HIV-1 treatment drug, indicative of the company's contribution to infectious disease therapeutics.
  • STP1002 - An anti-cancer drug, showcasing the company's commitment to oncology and the development of life-saving medications.
  • Healthcare Solutions - Provides an array of healthcare solutions in Bacchus, over-the-counter, consumer healthcare, and derma business areas, reflecting its diverse approach to healthcare.
  • CDMO Services - Offers Contract Development and Manufacturing Organization services, underlining its versatility in pharmaceutical manufacturing.
  • Imaging Equipment and ENT Workstation Products - Develops medical imaging equipment and ENT workstation products, leveraging its technological capabilities in medical devices.
  • Mineral Water - Markets mineral water under the Cheonnyeonsu brand name, expanding its business into consumer goods.
  • IT and Construction Services - Engages in IT and construction services, illustrating the company's multi-dimensional business model.
  • Glass Bottles, PET, and Corrugated Cardboard Boxes Production - Produces packaging materials, demonstrating its operational diversity and commitment to sustainability.
  • Foundry Equipment, Logistics, and Food and Beverage Businesses - Participates in a variety of sectors, highlighting its broad business interests and ability to innovate across industries.

Contact Information

Address: 64, Cheonho-daero, Seoul, South Korea, 02587
Phone: 82 2 920 8114